TYROSINE KINASE INHIBITOR
Clinical trials for TYROSINE KINASE INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new TYROSINE KINASE INHIBITOR trials appear
Sign up with your email to follow new studies for TYROSINE KINASE INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Dose drug combo tested for Tough-to-Treat lung cancer
Disease control CompletedThis study tested whether combining two existing cancer drugs—bevacizumab and a double dose of icotinib—works better than standard treatment for people with advanced non-small cell lung cancer that has a specific genetic change (EGFR L858R mutation). The trial involved 35 adults …
Matched conditions: TYROSINE KINASE INHIBITOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 02, 2026 02:57 UTC
-
Drugs before transplant may boost liver cancer survival
Disease control CompletedThis study looked back at nearly 500 liver cancer patients who received a liver transplant. Researchers wanted to see if taking certain cancer-fighting drugs (tyrosine kinase inhibitors) before the transplant surgery helped control the cancer better. They checked if the drugs led…
Matched conditions: TYROSINE KINASE INHIBITOR
Sponsor: Hu Liangshuo • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC